The U.S. Court of Appeals for the Federal Circuit (CAFC) on Tuesday in a precedential decision authored by Judge Taranto affirmed a New Jersey district court’s ruling that Teva Pharmaceuticals USA did not prove the asserted claims of Janssen Pharmaceuticals’ patent for dosing regimens of antipsychotic medications invalid for obviousness.

Full Article Available Here